Expert Speakers

2023 Speakers

Discover which expert speakers and KOLs are presenting at the 2nd Annual mRNA-Based Therapeutics Summit Europe this January 2023. 

BIOPHARMA LEADERS

Silvia Aiolli

Head of GRA mRNA Franchise

Sanofi

Heinrich Haas

Vice President - Ribonucleic Acid Formulation & Drug Delivery

BioNTech AG

Mostafa Nakach

Global Head of Process Engineering for Biologic Drug Product Development

Sanofi

Andreas Kuhn

Senior Vice President RNA Biochemistry & Manufacturing, RNA Biochemistry & Manufacturing

BioNTech

Adam Williams

Director, mRNA Commercial Strategy & Innovation

Pfizer

Charles Jones

Senior Director, mRNA Commercial Strategy & Innovation

Pfizer

Jason DelCarpini

Jason DelCarpini

Associate Director, Quantitative Bioanalytics

Moderna

Nelson Chau

Senior Vice President - Platform

Orna Therapeutics

Dr. Alexander Gebauer

Chief Executive Officer

Secarna Pharmaceuticals

Christian Maine

Compound Development Team Lead

Replicate Bioscience

Thomas Langenickel

Chief Medical Officer

Ethris GmbH

Metin Kurtoglu

Chief Medical Officer - Good Manufacturing Practice

Cartesian Therapeutics

De-Min Zhu

President & Chief Executive Officer

Cureport

Gregory Fiore

Co-Founder and Chief Executive Officer

Exacis Biotherapeutics

Hannu Rajaniemi

Co-Founder & Chief Executive Officer

Helix Nanotechnologies Inc.

Daniel Tondera

Head of Biology

Pantherna Therapeutics

Jenny van Asbeck

Chief Executive Officer

Mercurna

Danilo Casimiro

Chief Science Officer & Global Head, External Scientific Affairs, Vaccines R&D

Sanofi

Lorna Harries

Chief Scientific Officer - Research & Development Lead

Senisca

Louis St.L. O’Dea

Chief Medical Officer & President

BIORCHESTRA

Michiel Lodder

Chief Executive Officer

20Med Therapeutics

Suzanne Saffie-Siebert

Chief Executive Officer & Chairwoman

SiSaf Ltd

Aviad Pato

Head of Research & Natural Killer Cells

Gamida Cell

Oliver Ernst

Managing Director, Chief Executive Officer

NEUWAY Pharma

Heather Mallory

Investigator

GeneLeap Biotech

Adrien Villain

Bioinformatics Scientist

Sanofi

Covadonga Paneda

Chief Development Officer

Altamira Therapeutics

Thimmaiah Chendrimada

Chief Scientific Officer & Co-Founder

Chimeron Bio

Xinyue (Frank) Zhang

Investigator

GeneLeap Biotech

ACADEMIC & NFP LEADERS

Roy van der Meel

Assistant Professor

Eindhoven University of Technology

Camilla Foged

Professor - Vaccine Design & Delivery

University of Copenhagen

Steve Pascolo

Researcher

University Hospital Zurich

Giovanna Lollo

Associate Professor

Universite Claude Bernard Lyon

Raymond Schiffelers

Professor - Nanomedicine

Utrecht University

Nagy Habib

Head of Surgery Hammersmith Campus

Imperial College London

Khalid Khabar

Director of Molecular BioMedicine Program

King Faisal Specialist Hospital & Research Centre

Cees J.M. van Rijn

Professor of Nanotechnology & Microfluidics

University of Amsterdam

Harris Makatsoris

Academics Professor of Sustainable Manufacturing Systems

King’s College London

Koen Raemdonck

Professor

Ghent University

Zoltán Kis

Lecturer

University of Sheffield

Valeria Chiono

Full Professor

Politecnico di Torino

Anna Sarnefalt

Chemistry, Manufacturing & Controls Lead

CEPI

Paolo Lusso

Chief of Viral Pathogenesis Section

National Institute of Allergy & Infectious Diseases

Cristina Bruno

Program Manager - mRNA Technology Transfer

World Health Organization

LEADING SOLUTION PARTNERS

Dave Sokolowski

Global Workflow Manager Acid Therapeutics

Cytiva

Tomas Kostelec

Technology and Business Development Manager

Sartorius BIA Separations

Ioana Panait

Lead Research Analyst

Beacon Targeted Therapies

May Guo

Vice President, Nucleic Acids

Arranta Bio

Nuria Gomez Santos

Head of Process & Analytical Development

Catalent Inc.